The rationale for combined chemo/immunotherapy using a Toll-like receptor 3 (TLR3) agonist and tumour-derived exosomes in advanced ovarian cancer (Q60193091)
scientific article published on 01 March 2005
Language:
Current Data About The rationale for combined chemo/immunotherapy using a Toll-like receptor 3 (TLR3) agonist and tumour-derived exosomes in advanced ovarian cancer
(P31) (Q13442814)
(P248)
(P698) 15755631
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15755631%20AND%20SRC:MED&resulttype=core&format=json
(P813) Thursday, January 9, 2020

(P50) (Q38524031)
(P1545) 5
(P248)
(P698) 15755631
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15755631%20AND%20SRC:MED&resulttype=core&format=json
(P813) Thursday, January 9, 2020

(Q73147970)
(P1545) 6
(P248)
(P698) 15755631
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15755631%20AND%20SRC:MED&resulttype=core&format=json
(P813) Thursday, January 9, 2020

(P304) 2374-2378
(P248)
(P698) 15755631
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15755631%20AND%20SRC:MED&resulttype=core&format=json
(P813) Thursday, January 9, 2020

(P407) (Q1860)

(P433) 17-18
(P248)
(P698) 15755631
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15755631%20AND%20SRC:MED&resulttype=core&format=json
(P813) Thursday, January 9, 2020

(P478) 23
(P248)
(P698) 15755631
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15755631%20AND%20SRC:MED&resulttype=core&format=json
(P813) Thursday, January 9, 2020

(P577) Tuesday, March 1, 2005
(P248)
(P698) 15755631
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15755631%20AND%20SRC:MED&resulttype=core&format=json
(P813) Thursday, January 9, 2020

(P921) (Q408004)

(Q172341)
(P887)

(Q1427096)
(P887)

(P1433) (Q7907941)
(P248)
(P698) 15755631
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15755631%20AND%20SRC:MED&resulttype=core&format=json
(P813) Thursday, January 9, 2020

(P1476) "The rationale for combined chemo/immunotherapy using a Toll-like receptor 3 (TLR3) agonist and tumour-derived exosomes in advanced ovarian cancer" (language: en)
(P248)
(P698) 15755631
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15755631%20AND%20SRC:MED&resulttype=core&format=json
(P813) Thursday, January 9, 2020

(P2093) Adams M
(P1545) 1
(P248)
(P698) 15755631
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15755631%20AND%20SRC:MED&resulttype=core&format=json
(P813) Thursday, January 9, 2020

Navabi H
(P1545) 2
(P248)
(P698) 15755631
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15755631%20AND%20SRC:MED&resulttype=core&format=json
(P813) Thursday, January 9, 2020

Croston D
(P1545) 3
(P248)
(P698) 15755631
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15755631%20AND%20SRC:MED&resulttype=core&format=json
(P813) Thursday, January 9, 2020

Coleman S
(P1545) 4
(P248)
(P698) 15755631
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15755631%20AND%20SRC:MED&resulttype=core&format=json
(P813) Thursday, January 9, 2020

Jasani B
(P1545) 7
(P248)
(P698) 15755631
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15755631%20AND%20SRC:MED&resulttype=core&format=json
(P813) Thursday, January 9, 2020

Mason MD
(P1545) 8
(P248)
(P698) 15755631
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15755631%20AND%20SRC:MED&resulttype=core&format=json
(P813) Thursday, January 9, 2020

other details
description scientific article published on 01 March 2005

External Links
(P356) 10.1016/J.VACCINE.2005.01.014
(P698) 15755631